Yahoo Web Search

  1. Ads

    related to: safety, target

Search results

    • Why Is Mustang Bio (MBIO) Stock Up 347% Today?

      Why Is Mustang Bio (MBIO) Stock Up 347% Today?

      InvestorPlace· 5 hours ago

      The recent news includes favorable results from the company’s Phase 1/2 clinical trial of MB-106. This is a CD20-targeted, autologous CAR T-cell therapy...